1. Annualized clinical event rates during two-year follow-up are low in 27, 617 atrial fibrillation patients on edoxaban: results from the global noninterventional ETNA-AF program. (24th May 2021) Authors: Dinshaw, L; Unverdorben, M; Chen, C; De Caterina, R; Jiang, W; Kim, Y-H; Koretsune, Y; Morrone, D; Pecen, L; Reimitz, P-E; Wang, C-C; Yamashita, T; Kirchhof, P Journal: Europace Issue: Volume 23:Supplement 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparison of clinical outcomes with edoxaban versus apixaban, dabigatran, rivaroxaban, and vitamin K antagonist in patients with atrial fibrillation in Germany: a real-world cohort study. (25th November 2020) Authors: Marston, X.L; Wang, R; Yeh, Y.C; Zimmermann, L; Ye, X; Gao, X; Unverdorben, M Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Edoxaban treatment in real-world practice is highly concordant with ESC atrial fibrillation guidelines: results from the non-interventional global ETNA-AF program. (14th October 2021) Authors: Morrone, D; Chen, C; Dinshaw, L; Jiang, W; Kim, Y.-H; Kirchhof, P; Koretsune, Y; Pecen, L; Reimitz, P.-E; Wang, C.-C; Yamashita, T; Unverdorben, M; De Caterina, R Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Edoxaban treatment of elderly patients with atrial fibrillation in routine clinical practice: 1-year results of the non-interventional Global ETNA-AF program. (25th November 2020) Authors: Yamashita, T; Wang, C.C; Kim, Y.-H; De Caterina, R; Kirchhof, P; Reimitz, P; Chen, C; Unverdorben, M; Koretsune, Y Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effectiveness and safety of edoxaban in 27, 333 patients from ETNA-AF with and without a history of intracranial haemorrhage after 2 years of treatment. (19th May 2022) Authors: Moser, J; Unverdorben, M; Wang, CC; Bruggenjurgen, B; Lee, BC; Chen, C; Pecen, L; Yamashita, T; De Caterina, R; Kirchhof, P Journal: Europace Issue: Volume 24:Supplement 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Effectiveness and safety of edoxaban in atrial fibrillation patients from the ETNA-AF global registry. (14th October 2021) Authors: De Caterina, R; Wang, R; Shi, L; Pecen, L; Ye, X; Reimitz, P.-E; Chen, C; Unverdorben, M; Giugliano, R.P Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Low bleeding and stroke rates with minor age-dependent increase confirm the safety and effectiveness of edoxaban in patients with atrial fibrillation across age groups: Two-year results from ETNA-AF. (24th May 2021) Authors: Morrone, D; Unverdorben, M; Chen, C; Dinshaw, L; Jiang, W; Kim, Y-H; Kirchhof, P; Koretsune, Y; Pecen, L; Reimitz, P-E; Wang, C-C; Yamashita, T; De Caterina, R Journal: Europace Issue: Volume 23:Supplement 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Management of edoxaban in patients undergoing multiple procedures: a subanalysis of the EMIT-AF/VTE program. (19th May 2022) Authors: Saxena, M; Von Heymann, C; Santamaria, A; Jin, J; Chen, C; Borrow, A; Vanassche, T; Unverdorben, M; Colonna, P Journal: Europace Issue: Volume 24:Supplement 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Periprocedural anticoagulation management in edxoaban patients undergoing catheter-based cardiovascular procedures: analyses of the noninterventional global EMIT study. (24th May 2021) Authors: Vanassche, T; Colonna, P; Santamaria, A; Chen, C; Von Heymann, C; Jin, J; Saxena, M; Jiang, W; Unverdorben, M Journal: Europace Issue: Volume 23:Supplement 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Periprocedural management of patients on edoxaban undergoing pacemaker and cardiac monitoring device implantation - a sub-analysis of the EMIT-AF/VTE study. (24th May 2021) Authors: Unverdorben, M; Colonna, P; Von Heymann, C; Santamaria, A; Saxena, M; Vanassche, T; Wilkins, R; Chen, C Journal: Europace Issue: Volume 23:Supplement 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗